E-Cadherin/β-catenin complex plays an important role in maintaining epithelial integrity and disrupting this complex affect not only the adhesive repertoire of a cell, but also the Wnt-signaling pathway. Aberrant expression of the complex is associated with a wide variety of human malignancies and disorders of fibrosis resulting from epithelial-mesenchymal transition. These associations provide insights into the complexity that is likely responsible for the fibrosis/tumor suppressive action of E-cadherin/β-catenin.
1. Introduction
Cell-cell junctions are important to maintain cell and tissue polarity and integrity. In general, vertebrate animals possess three intercellular junction systems: gap junctions, which serve as intercellular channels that permit direct cell-cell transfer of ions and small molecules; tight junctions, the primary cellular determinant of epithelial barrier function; anchoring junctions, which includes desmosomes and adheren junctions (AJs) that associate with the cortical cytoskeleton to mediate cell and tissue behavior [1]. Among constituent structural molecules that assemble to form AJ, cadherin/catenin-based anchoring junctions organize and tether microfilaments to maintain cell adhesive properties and integrate intra- and intercellular signaling, including regulation of nuclear functions and transcription pathways [2, 3]. This paper focuses on the role of E-cadherin/β-catenin protein complexes in forming the epithelial barrier and discusses the effects of dysregulating the assembly of the E-cadherin/β-catenin adhesion complex in fibrotic diseases and cancer.
2. The Cadherin/Catenin Complex
Cadherins constitute a large family of cell surface proteins, including E (epithelial)-, N (neural)-, VE (vascular-endothelial)-, P (placental)-, R (retinal)-, and K (kidney)-cadherins [4]. Classical cadherins are single-pass transmembrane proteins which participate in Ca2+-dependent cell adhesion that is necessary to form solid tissues [2, 5]. E-cadherin is functionally linked to the generation of a polarized epithelial phenotype [6, 7]. The extracellular region of E-cadherin extends from the cell surface and bind to cadherins present on adjacent cells [8] whereas its intracellular region contains binding sites to interact with catenins and other regulatory proteins (Figure 1) [9]. Immunoprecipitation of detergent-solubilised cell extracts with anticadherin antibodies identified major proteins involved in the formation of cadherin: p120-, α-, β-, and γ-catenin (plakoglobin) [10, 11]. P120 catenin acts to bind to the juxtamembrane portion, and β-catenin or plakoglobin binds to the carboxy-terminal 100 amino acids of the cadherin cytoplasmic region [12]. α-catenin links β-catenin to actin, which in turn has the ability to promote AJ protein clustering and stabilization of cell adhesion [13]. To allow for a continuous assembly of cadherin/catenin complexes in AJs, cadherins can be constitutively endocytosed and recycled to the cell surface [14, 15]. In Drosophila epithelial cells, exocyst components Sec5, Sec6, and Sec15 directly regulate the trafficking of E-cadherin to AJs via interactions with β-catenin [16]. Images from time-lapse microscopy using photoactivatable-GFP-tagged β-catenin in A431 cells show that β-catenin, internalised with E-cadherin, accumulates at the perinuclear endocytic recycling compartment (ERC) upon AJ dissociation [17].
E-cadherin/β-catenin complex in epithelial cell-cell adhesion and Wnt signalling.
Other than their structural role in stabilizing cell-cell contact, components of cadherin-catenin complex serve a role in activating several key signal transduction networks. β-catenin is a key regulator in the canonical Wnt signaling, where cytoplasmic β-catenin translocates to the nucleus and functions as an activator for T-cell factor (TCF)/lymphoid enhancer factor (LEF) transcription factors that result in a subset of cellular effects involving cellular adhesion, tissue morphogenesis, and tumor development (Figure 1) [18, 19]. In the absence of Wnt signals, a multiprotein destruction complex including axin and the adenomatous polyposis coli (APC) facilitates phosphorylation of serine residues in the N terminus of cytosolic β-catenin, which leads to its ubiquitination and proteosomal destruction (Figure 1) [20]. Wnt signaling inhibits this degradative process by binding to Frizzled receptors and signaling through the associated low-density lipoprotein-related proteins, LRP5/6, thereby allowing β-catenin to accumulate in the cytosol and enter the nucleus (Figure 1) [21–23]. Dissociation of AJ can influence E-cadherin endocytosis, β-catenin levels in the ERC, and β-catenin substrate levels available downstream for the Wnt pathway. One potential determinant in the structural integrity of the cadherin/β-catenin complex may lie in its phosphorylation status. Phosphorylation of E-cadherin or β-catenin by Ser/Thr kinase CK II stabilizes the complex [24, 25]. However, tyrosine 654 phosphorylation of β-catenin by an intracellular signaling event disrupts the E-cadherin/β-catenin complex and cell adhesion [26, 27]. The phosphorylation of β-catenin at tyrosine 489 or 142 strengthens Wnt signaling [28, 29]. Tyrosine phosphorylation can release β-catenin from E-cadherin, decrease cell-cell junction adhesion, and increase cell migration and invasiveness [30].
4. E-Cadherin/β-Catenin and Epithelial-Mesenchymal Transition (EMT)
E-cadherin/β-catenin protein complexes are involved actively in epithelial to mesenchymal (EMT) and mesenchymal to epithelial (MET) transitions, which play a particularly important role in embryo development, tissue fibrosis, and cancer progression. The process of EMT is characterized by differentiated epithelial cells that undergo a phenotypic conversion that gives rise to the matrix-producing fibroblasts and myofibroblasts. Epithelial cells lose their marker proteins such as E-cadherin, zonula occludens-1 (ZO-1), and cytokeratin, and gain of a mesenchymal phenotype with expression of mesenchymal proteins including vimentin, α-smooth muscle actin (α-SMA), and fibroblast-specific protein-1 (FSP1), and production of interstitial matrix components type I collagen and fibronectin [31, 32]. Cell contacts are critical determinants of EMT. Loss of E-cadherin likely promotes β-catenin release and facilitates EMT, whereas the expression of E-cadherin can reverse the transformed phenotype [33–36]. β-catenin plays an important role in the TGF-β1- and cell contact-dependent, synergistic induction of EMT [37]. In the absence of TGF-β1, both E-cadherin and β-catenin are rapidly degraded following contact disassembly. However, TGF-β1 induces β-catenin dissociation from epithelial contacts and stabilizes β-catenin in the cytoplasm, making it available for nuclear import [38, 39]. So the loss of cell-cell adhesion triggers EMT and is associated with diseases involving EMT.
5. The Role of E-Cadherin/β-Catenin in Fibrosis
Fibrosis is an active extracellular matrix (ECM) biosynthetic process and represents the final pathway of chronic failure of many organs. Evidence of EMT has been reported in kidney, lung, liver, eye, and serosal membranes suggesting that EMT can be closely associated with the pathogenesis of fibrotic disorders in those organs [40]. E-cadherin downregulation responsible for the loss of cell-cell adhesion and β-catenin upregulation for the subsequent transcriptome program of EMT are two important changes in the process of fibrosis. Iwano et al. found that 36% of renal fibroblasts, the main effector cells in kidney fibrosis responsible for ECM production, originate from renal tubular epithelial cells via EMT [41] despite conflicting evidence about the relative importance of various sources of myofibroblasts was reported [42]. Decreased expression of E-cadherin and early expression of EMT-related markers as well as β-catenin cytoplasmic translocation have been detected in kidney specimens from patients with glomerulonephritis and diabetic and chronic allograft nephropathies [43–46]. Similar changes appear in lung epithelial cells of patients with idiopathic pulmonary fibrosis and usual interstitial pneumonia [47, 48], and in biliary epithelial cells of patients with primary biliary cirrhosis, primary sclerosing cholangitis and alcoholic liver disease [49]. The transition of retinal pigment epithelial cells into myofibroblasts is observed in patients with proliferative vitreoretinopathy, and peritoneal mesothelial cells from fluid effluents of dialyzed patients show a mesenchymal phenotype with reduced E-cadherin expression [50–52]. Nuclear β-catenin immunoreactivity suggests aberrant activation of Wnt/β-catenin signaling and subsequent EMT in the pathogenesis of a number of fibrotic disorders. In addition to the nuclear translocation of β-catenin, we previously reported that matrix metalloproteinase (MMP)-mediated E-cadherin disruption led directly to tubular epithelial cell EMT via Slug and that MMP-9 secreted by macrophages is capable of initiating tubular cell EMT by disruption of the E-cadherin/β-catenin complex [45, 53].
6. The Role of E-Cadherin/β-Catenin in Cancer
EMT is an important mechanism for the cancer development and initial step of metastasis [54, 55]. Disruption of E-cadherin/β-catenin might contribute to tumor aberrant morphogenetic effects. Loss of E-cadherin expression or loss of its normal localization at cell-cell contacts is consistently observed at sites of EMT during tumor progression. E-cadherin expression level is often inversely correlated with the tumor malignancy [56–58]. Cases of invasive lobular carcinoma have been associated commonly with the loss of E-cadherin expression as a result of E-cadherin gene mutation and promoter hypermethylation [59, 60]. Evidence from animal models has shown that conditional deletion of E-cadherin in p53-deficient mouse mammary epithelium promoted tumor initiation and progression to invasion and metastasis [61]. β-catenin is a critical element in the canonical Wnt signaling of tumorigenesis. Activating mutations of β-catenin or inactivating mutations of APC or Axin have been found to be associated with a wide variety of human malignancies, such as colorectal, ovarian endometrial, heptocellular, desmoid and pancreatic tumors [62, 63]. Cancer studies suggest that deregulated β-catenin signaling promotes tumorigenesis by inducing expression of oncogenes such as c-myc and cyclin D1 [64–66]. Stabilizing mutations in the β-catenin N-terminal sequence have been found in 25% of metaplastic breast cancers [67]. Increased cytoplasmic and nuclear β-catenin levels have been observed in 40% of primary breast cancers and correlated with poor prognosis and worse patient survival [68–73].
7. Concluding Remarks
Taken together, these data show that in addition to their adhesive functions, the E-cadherin/β-catenin complex also plays a crucial role in modulating Wnt signaling. E-cadherin/β-catenin complex maintains integrity of epithelial cell-cell contact and keeps Wnt/β-catenin signals in check. Loss of cadherin-mediated cell adhesion can promote β-catenin signaling. The E-cadherin/β-catenin complex is very important in maintaining epithelial morphology, and high-affinity E-cadherin/β-catenin interaction can be disrupted during oncogenesis and fibrosis. This complex is dysregulated in response to mediators of inflammation, including MMPs, growth factors, and cytokines, suggesting that dysregulation of E-cadherin/β-catenin association holds promise as a new target for therapy of fibrotic disorders and cancer.
GreenK. J.GetsiosS.TroyanovskyS.GodselL. M.Intercellular junction assembly, dynamics, and homeostasis201022a0001252-s2.0-7795666091910.1101/cshperspect.a000125GumbinerB. M.Regulation of cadherin-mediated adhesion in morphogenesis2005686226342-s2.0-2314444264510.1038/nrm1699KurokawaH.IkuraM.[Perspectives on structure elucidation of the cadherin-catenin complex]20067875956002-s2.0-33750118322HulpiauP.van RoyF.Molecular evolution of the cadherin superfamily20094123493692-s2.0-5694908441610.1016/j.biocel.2008.09.027TepassU.Genetic analysis of cadherin function in animal morphogenesis19991155405482-s2.0-003284348710.1016/S0955-0674(99)00025-3WheelockM. J.JensenP. J.Regulation of keratinocyte intercellular junction organization and epidermal morphogenesis by E-cadherin199211724154252-s2.0-002653415210.1083/jcb.117.2.415JeanesA.GottardiC. J.YapA. S.Cadherins and cancer: how does cadherin dysfunction promote tumor progression?20082755692069292-s2.0-5674917643710.1038/onc.2008.343ShapiroL.WeisW. I.Structure and biochemistry of cadherins and catenins200913a0030532-s2.0-7714914847910.1101/cshperspect.a003053Perez-MorenoM.FuchsE.Catenins: keeping cells from getting their signals crossed20061156016122-s2.0-3375045973810.1016/j.devcel.2006.10.010OzawaM.BarbaultH.KemlerR.The cytoplasmic domain of the cell adhesion molecule uvomorulin assoicates with three independent proteins structurally related in different species198986171117172-s2.0-0024451982OzawaM.KemlerR.Altered cell adhesion activity by pervanadate due to the dissociation of α-catenin from the E-cadherin·catenin complex199827311616661702-s2.0-003251329710.1074/jbc.273.11.6166ReynoldsA. B.CarnahanR. H.Regulation of cadherin stability and turnover by p120ctn: implications in disease and cancer20041566576632-s2.0-444431708510.1016/j.semcdb.2004.09.003HiranoS.KimotoN.ShimoyamaY.HirohashiS.TakeichiM.Identification of a neural α-catenin as a key regulator of cadherin function and multicellular organization19927022933012-s2.0-002663099410.1016/0092-8674(92)90103-JIvanovA. I.NusratA.ParkosC. A.Endocytosis of the apical junctional complex: mechanisms and possible roles in regulation of epithelial barriers20052743563652-s2.0-1784439715910.1002/bies.20203YapA. S.CramptonM. S.HardinJ.Making and breaking contacts: the cellular biology of cadherin regulation20071955085142-s2.0-3554895830210.1016/j.ceb.2007.09.008LangevinJ.MorganM. J.RosséC.RacineV.SibaritaJ. B.ArestaS.MurthyM.SchwarzT.CamonisJ.BellaïcheY.Drosophila exocyst components sec5, sec6, and Sec15 regulate DE-cadherin trafficking from recycling endosomes to the plasma membrane2005933653762-s2.0-2414447793610.1016/j.devcel.2005.07.013KamY.QuarantaV.Cadherin-bound β-catenin feeds into the Wnt pathway upon adherens junctions dissociation: evidence for an intersection between β-catenin pools200942e45802-s2.0-6144923822510.1371/journal.pone.0004580e4580CleversH.Wnt/β-catenin signaling in development and disease200612734694802-s2.0-3374680839810.1016/j.cell.2006.10.018GrigoryanT.WendP.KlausA.BirchmeierW.Deciphering the function of canonical Wnt signals in development and disease: conditional loss- and gain-of-function mutations of β-catenin in mice20082217230823412-s2.0-5114911889210.1101/gad.1686208LuoW.LinS. C.Axin: a master scaffold for multiple signaling pathways2004133991132-s2.0-184250765010.1159/000076563AmitS.HatzubaiA.BirmanY.AndersenJ. S.Ben-ShushanE.MannM.Ben-NeriahY.AlkalayI.Axin-mediated CKI phosphorylation of β-catenin at Ser 45: a molecular switch for the Wnt pathway2002169106610762-s2.0-003657101110.1101/gad.230302DixeliusJ.CrossM.MatsumotoT.SasakiT.TimplR.Claesson-WelshL.Endostatin regulates endothelial cell adhesion and cytoskeletal organization2002627194419472-s2.0-0036531963YanagawaS.MatsudaY.LeeJ. S.MatsubayashiH.SeseS.KadowakiT.IshimotoA.Casein kinase I phosphorylates the Armadillo protein and induces its degradation in Drosophila2002217173317422-s2.0-003700723110.1093/emboj/21.7.1733LickertH.BauerA.KemlerR.StappertJ.Casein kinase II phosphorylation of E-cadherin increases E-cadherin/β- catenin interaction and strengthens cell-cell adhesion20002757509050952-s2.0-003468143010.1074/jbc.275.7.5090BekS.KemlerR.Protein kinase CKII regulates the interaction of β-catenin with α-catenin and its protein stability2002115part 24474347532-s2.0-003711560510.1242/jcs.00154BehrensJ.VakaetL.FriisR.WinterhagerE.Van RoyF.MareelM. M.BirchmeierW.Loss of epithelial differentiation and gain of invasiveness correlates with tyrosine phosphorylation of the E-cadherin/β-catenin complex in cells transformed with a temperature-sensitive v-SRC gene199312037577662-s2.0-002750702810.1083/jcb.120.3.757TaddeiM. L.ChiarugiP.CirriP.BuricchiF.FiaschiT.GiannoniE.TaliniD.CozziG.FormigliL.RaugeiG.RamponiG.β-catenin interacts with low-molecular-weight protein tyrosine phosphatase leading to cadherin-mediated cell-cell adhesion increase20026222648964992-s2.0-0037112509BrembeckF. H.Schwarz-RomondT.BakkersJ.WilhelmS.HammerschmidtM.BirchmeierW.Essential role of BCL9-2 in the switch between β-catenin's adhesive and transcriptional functions20041818222522302-s2.0-444427619410.1101/gad.317604RheeJ.BuchanT.ZukerbergL.LilienJ.BalsamoJ.Cables links Robo-bound Abl kinase to N-cadherin-bound β-catenin to mediate Slit-induced modulation of adhesion and transcription2007988838922-s2.0-3454757567710.1038/ncb1614HülskenJ.BirchmeierW.BehrensJ.E-cadherin and APC compete for the interaction with β-catenin and the cytoskeleton19941276, part 2206120692-s2.0-002857255610.1083/jcb.127.6.2061RastaldiM. P.Epithelial-mesenchymal transition and its implications for the development of renal tubulointerstitial fibrosis20061944074122-s2.0-37849189626SavagnerP.Leaving the neighborhood: molecular mechanisms involved during epithelial-mesenchymal transition200123109129232-s2.0-003479870710.1002/bies.1132AuerspergN.PanJ.GroveB. D.PetersonT.FisherJ.Maines-BandieraS.SomasiriA.RoskelleyC. D.E-cadherin induces mesenchymal-to-epithelial transition in human ovarian surface epithelium19999611624962542-s2.0-003299180410.1073/pnas.96.11.6249HayE. D.ZukA.Transformations between epithelium and mesenchyme: normal, pathological, and experimentally induced19952646786902-s2.0-0029157019CanoA.Pérez-MorenoM. A.RodrigoI.LocascioA.BlancoM. J.del BarrioM. G.PortilloF.NietoM. A.The transcription factor Snail controls epithelial-mesenchymal transitions by repressing E-cadherin expression20002276832-s2.0-003378484310.1038/35000025VleminckxK.VakaetL.MareelM.FiersW.Van RoyF.Genetic manipulation of E-cadherin expression by epithelial tumor cells reveals an invasion suppressor role19916611071192-s2.0-0025818032MassziA.FanL.RosivallL.McCullochC. A.RotsteinO. D.MucsiI.KapusA.Integrity of cell-cell contacts is a critical regulator of TGF-β1-induced epithelial-to-myofibroblast transition: role for β-catenin20041656195519672-s2.0-9644274187MassziA.di CianoC.SirokmányG.ArthurW. T.RotsteinO. D.WangJ.McCullochC. A. G.RosivallL.MucsiI.KapusA.Central role for Rho in TGF-β1-induced α-smooth muscle actin expression during epithelial-mesenchymal transition20032845F911F9242-s2.0-0037405501TianY. C.FraserD.AttisanoL.PhillipsA. O.TGF-β1-mediated alterations of renal proximal tubular epithelial cell phenotype20032851F130F1422-s2.0-0037707630GuarinoM.TosoniA.NebuloniM.Direct contribution of epithelium to organ fibrosis: epithelial-mesenchymal transition20094010136513762-s2.0-6994912474910.1016/j.humpath.2009.02.020IwanoM.PliethD.DanoffT. M.XueC.OkadaH.NeilsonE. G.Evidence that fibroblasts derive from epithelium during tissue fibrosis200211033413502-s2.0-003632200710.1172/JCI200215518LinS. L.KisselevaT.BrennerD. A.DuffieldJ. S.Pericytes and perivascular fibroblasts are the primary source of collagen-producing cells in obstructive fibrosis of the kidney20081736161716272-s2.0-5714911372810.2353/ajpath.2008.080433RastaldiM. P.FerrarioF.GiardinoL.Dell'AntonioG.GrilloC.GrilloP.StrutzF.MüllerG. A.ColasantiG.D'AmicoG.Epithelial-mesenchymal transition of tubular epithelial cells in human renal biopsies20026211371462-s2.0-003631831710.1046/j.1523-1755.2002.00430.xRobertsonH.AliS.McDonnellB. J.BurtA. D.KirbyJ. A.Chronic renal allograft dysfunction: the role of T cell-mediated tubular epithelial to mesenchymal cell transition20041523903972-s2.0-094227628710.1097/01.ASN.0000108521.39082.E1ZhengG.LyonsJ. G.ThianK. T.WangY.HsuT. T.MinD.SuccarL.RanganG. K.HuM.HendersonB. R.AlexanderS. I.HarrisD. C. H.Disruption of E-cadherin by matrix metalloproteinase directly mediates epithelial-mesenchymal transition downstream of transforming growth factor-β1 in renal tubular epithelial cells200917525805912-s2.0-6844909405610.2353/ajpath.2009.080983BediS.VidyasagarA.DjamaliA.Epithelial-to-mesenchymal transition and chronic allograft tubulointerstitial fibrosis2008221152-s2.0-3624892939010.1016/j.trre.2007.09.004ThannickalV. J.ToewsG. B.WhiteE. S.LynchJ. P.MartinezF. J.Mechanisms of pulmonary fibrosis2004553954172-s2.0-154232901010.1146/annurev.med.55.091902.103810WillisB. C.LieblerJ. M.Luby-PhelpsK.NicholsonA. G.CrandallE. D.du BoisR. M.BorokZ.Induction of epithelial-mesenchymal transition in alveolar epithelial cells by transforming growth factor-β1: potential role in idiopathic pulmonary fibrosis20051665132113322-s2.0-17844384822RygielK. A.RobertsonH.MarshallH. L.PekalskiM.ZhaoL.BoothT. A.JonesD. E. J.BurtA. D.KirbyJ. A.Epithelial-mesenchymal transition contributes to portal tract fibrogenesis during human chronic liver disease20088821121232-s2.0-3854914388310.1038/labinvest.3700704SaikaS.TGFbeta pathobiology in the eye2006862106-115GamulescuM. A.ChenY.HeS.SpeeC.JinM.RyanS. J.HintonD. R.Transforming growth factor β2-induced myofibroblastic differentiation of human retinal pigment epithelial cells: regulation by extracellular matrix proteins and hepatocyte growth factor20068312122222-s2.0-3364688954010.1016/j.exer.2005.12.007Yáñez-MóM.Lara-PezziE.SelgasR.Ramírez-HuescaM.Domínguez-JiménezC.Jiménez-HeffernanJ. A.AguileraA.Sánchez-TomeroJ. A.BajoM. A.ÁlvarezV.CastroM.del PesoG.CirujedaA.GamalloC.Sánchez-MadridF.López-CabreraM.Peritoneal dialysis and epithelial-to-mesenchymal transition of mesothelial cells200334854034132-s2.0-003747288110.1056/NEJMoa020809TanT. K.ZhengG.HsuT. T.WangY.LeeV. W. S.TianX.WangY.CaoQ.WangY.HarrisD. C. H.Macrophage matrix metalloproteinase-9 mediates epithelial-mesenchymal transition in vitro in murine renal tubular cells20101763125612702-s2.0-7774929174510.2353/ajpath.2010.090188WuY.ZhouB. P.New insights of epithelial-mesenchymal transition in cancer metastasis200840764365010.1111/j.1745-7270.2008.00443.xCardiffR. D.Epithelial to mesenchymal transition tumors: fallacious or snail's pace?20051124, part 1853485372-s2.0-2934446146410.1158/1078-0432.CCR-05-2250YapA. S.The morphogenetic role of cadherin cell adhesion molecules in human cancer: a thematic review19981642522612-s2.0-0031894062CowinP.RowlandsT. M.HatsellS. J.Cadherins and catenins in breast cancer20051754995082-s2.0-2464448744310.1016/j.ceb.2005.08.014JunghansD.HaasI. G.KemlerR.Mammalian cadherins and protocadherins: about cell death, synapses and processing20051754464522-s2.0-2464449831310.1016/j.ceb.2005.08.008ChengC. W.WuP. E.YuJ. C.HuangC. S.YueC. T.WuC. W.ShenC. Y.Mechanisms of inactivation of E-cadherin in breast carcinoma: modification of the two-hit hypothesis of tumor suppressor gene20012029381438232-s2.0-003596331410.1038/sj.onc.1204505BlancoM. J.Moreno-BuenoG.SarrioD.LocascioA.CanoA.PalaciosJ.NietoM. A.Correlation of Snail expression with histological grade and lymph node status in breast carcinomas20022120324132462-s2.0-003704650510.1038/sj/onc/1205416DerksenP. W.LiuX.SaridinF.van der GuldenH.ZevenhovenJ.EversB.van BeijnumJ. R.GriffioenA. W.VinkJ.KrimpenfortP.PeterseJ. L.CardiffR. D.BernsA.JonkersJ.Somatic inactivation of E-cadherin and p53 in mice leads to metastatic lobular mammary carcinoma through induction of anoikis resistance and angiogenesis20061054374492-s2.0-3375061465110.1016/j.ccr.2006.09.013PeiferM.PolakisP.Wnt signaling in oncogenesis and embryogenesis—a look outside the nucleus20002875458160616092-s2.0-003405306910.1126/science.287.5458.1606PolakisP.Wnt signaling and cancer20001415183718512-s2.0-0033895709HeT. C.SparksA. B.RagoC.HermekingH.ZawelL.da CostaL. T.MorinP. J.VogelsteinB.KinzlerK. W.Identification of c-MYC as a target of the APC pathway19982815382150915122-s2.0-003248343910.1126/science.281.5382.1509TetsuO.McCormickF.β-catenin regulates expression of cyclin D1 in colon carcinoma cells199939867264224262-s2.0-003311980110.1038/18884ShtutmanM.ZhurinskyJ.SimchaI.AlbaneseC.D'AmicoM.PestellR.Ben-Ze'evA.The cyclin D1 gene is a target of the β-catenin/LEF-1 pathway19999610552255272-s2.0-003354584510.1073/pnas.96.10.5522HayesM. J.ThomasD.EmmonsA.GiordanoT. J.KleerC. G.Genetic changes of Wnt pathway genes are common events in metaplastic carcinomas of the breast20081413403840442-s2.0-4824915583410.1158/1078-0432.CCR-07-4379RyoA.NakamuraM.WulfG.LiouY. C.LuK. P.Pin1 regulates turnover and subcellular localization of β-catenin by inhibiting its interaction with APC2001397938012-s2.0-003484095010.1038/ncb0901-793LinS. Y.XiaW.WangJ. C.KwongK. Y.SpohnB.WenY.PestellR. G.HungM. C.β-catenin, a novel prognostic marker for breast cancer: its roles in cyclin D1 expression and cancer progression2000978426242662-s2.0-003463615310.1073/pnas.060025397OzakiS.IkedaS.IshizakiY.KuriharaT.TokumotoN.IsekiM.ArihiroK.KataokaT.OkajimaM.AsaharaT.Alterations and correlations of the components in the Wnt signaling pathway and its target genes in breast cancer2005146143714432-s2.0-33644691659SormunenR. T.LeongA. S. Y.VääräniemiJ. P.FernandoS. S. E.EskelinenS. M.Immunolocalization of the fodrin, E-cadherin, and β-catenin adhesion complex in infiltrating ductal carcinoma of the breast-Comparison with an in vitro model199918744164232-s2.0-0032980637KarayiannakisA. J.NakopoulouL.GakiopoulouH.KeramopoulosA.DavarisP. S.PignatelliM.Expression patterns of β-catenin in in situ and invasive breast cancer2001271313610.1053/ejso.1999.1017PrasadC. P.MirzaS.SharmaG.PrashadR.DattaGuptaS.RathG.RalhanR.Epigenetic alterations of CDH1 and APC genes: relationship with activation of Wnt/β-catenin pathway in invasive ductal carcinoma of breast2008839-103183252-s2.0-4954908685610.1016/j.lfs.2008.06.019